MedPath

Quinidine gluconate

Rx Only QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS USP

Approved
Approval ID

4db375a3-0cff-4fa7-af7a-2a49e0b922d0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2021

Manufacturers
FDA

Eywa Pharma Inc

DUNS: 080465609

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Quinidine gluonate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71930-016
Application NumberANDA212589
Product Classification
M
Marketing Category
C73584
G
Generic Name
Quinidine gluonate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 29, 2021
FDA Product Classification

INGREDIENTS (8)

QUINIDINE GLUCONATEActive
Quantity: 324 mg in 1 1
Code: R6875N380F
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE 2208 (100 MPA.S)Inactive
Code: B1QE5P712K
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM ALGINATEInactive
Code: C269C4G2ZQ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Quinidine gluconate - FDA Drug Approval Details